Aevi Genomic Medicine, Inc. announced the retirement of Wilbur H. Gantz's from the Board of Directors and Audit Committee, the company currently has only two independent directors on its Audit Committee. The company has until the earlier of its next annual meeting of stockholders or June 14, 2019 to identify an additional independent director to be appointed to the Audit Committee.